Patient Input Needed For Review Of New Migraine Medicine By Nov 30

Photo copyright The Headache & Migraine Policy Forum The Institute for Clinical and Economic Review ( ICER ) is assessing the firs...

Patient Input Needed For Review Of New Migraine Medicines By May 8

The Institute for Clinical and Economic Review ( ICER ) is assessing the new class of CGRP inhibitor medicines for migraine prevention....

Does Icer's One-Size-Fits-All Approach Fit Your #Migraine?

For women and men with migraine, the only thing better than making a headache stop is preventing it altogether. New drugs known as CGRP ...

*Last Chance* Deadline To Submit Comments To Icer Is Tomorrow, May 8

The Institute for Clinical and Economic Review ( ICER ) is assessing the new class of CGRP inhibitor medicines for migraine preventio...

My Patient Input Submission For Icer's Draft Evidence Report

With tomorrow being the deadline to submit public comments on ICER's review of the new class of CGRP inhibitor medicines for migraine pr...

Focus - A Research Study Of Cgrp In Migraine Patients

Have you been diagnosed with Migraine? The FOCUS study is recruiting participants and aims to test an investigational medication fo...

Fda Announces Approval Of Aimovig For Migraine Prevention

Novartis today announced that the US Food and Drug Administration (FDA) has approved Aimovig™ (erenumab-aooe) for the preventive treatment...

Will Insurance Companies Cover The New Cgrp Drug?

Yay! The FDA has approved Amgen and Novartis' CGRP preventive medication, Aimovig, for the prevention of migraine. But how accessi...